GALVmed continues to collaborate with partners and key public and private stakeholders to transform the lives of small-scale producers across Africa and South Asia through improved animal health.

In 2021, Ceva Animal Health teamed with GALVmed, with the support of the Gates Foundation, to implement PREVENT. Between 2021 and 2025, 37 hatcheries in 11 countries produced 202 million day-old chicks, creating a net economic benefit of $43 million over the course of the project.

Mentoring has the power to positively impact everyone involved, as evidenced by an initiative to mentor field technicians in Tanzania to provide inclusive veterinary extension to small-scale poultry producers.

Gender gaps in men and women’s access to resources, inputs and services mean their work in agricultural value chains falls far short of their potential in terms of scale, productivity, […]

Women make up at least 43 per cent of the agricultural labour force in developing countries, but they are restricted by social norms and lack of access to resources which may enable them to benefit from digital services.

With a rapidly growing population and demand for animal-derived protein, enabling the veterinary sector to address the diverse needs and challenges of small-scale producers is not only possible, but also critical to Africa’s sustainable development.

The misuse of antibiotics in both human and animal health has created an urgent health emergency globally. The resistance of microbes to antibiotics that are constantly used to combat them makes infections harder to treat, creating an antimicrobial resistance (AMR) crisis directly responsible for up to 1.27 million global human deaths as of 2019.

Understanding how adoption translates into economic and other benefits for SSPs is central to our mission. Monitoring and Evaluation (M&E) gives us a structured way to assess these outcomes.

At GALVmed, Monitoring and Evaluation (M&E) is not an afterthought. It is integrated from the very start of the development of new projects and programmes. This approach ensures that our projects are designed with a clear vision of impact.

As of June 2024, the Mutual Recognition Procedure has been extended to also include registration of veterinary ectoparasiticides.